tirzepatide heart attack An Observational Study of Cardiovascular Outcomes of vs Glucagon-Like Peptide-1 Receptor Agonists The Cardiovascular Effect of Tirzepatide:

It stimulates insulin release when blood sugar rises and inhibits glucagon release

doi:10.1186/1758-5996-5-47 12

Superior Blood Sugar Control Lets talk diabetes management first

The combination group lost less than 1% of their weight as lean mass over 16 weeks, compared with 34% in the semaglutide-alone group

The authors said: In this 72-week trial in participants with obesity, tirzepatide once weekly provided substantial reductions in body weight, consistent across all BMI categories, with improvement in body composition that was clinically meaningful and consistent across age groups. Dr Louis Aronne, from Weill Cornell Medicine in New York and a consultant to Eli Lilly, who presented the findings, said there was a need to understand the effect of weight loss on fat mass and lean mass, particularly in the elderly

I am taking semaglutide to help with weight loss, and I have been very successful with it